CSEM’s Post

The Flinn Foundation and SRI International are working with Arizona leaders to design the third iteration of Arizona’s Bioscience Roadmap, which has guided development of our bioscience sector since 2002.   SRI has now launched a survey to understand Arizona’s bioscience ecosystem competitiveness, talent pipeline, organizational needs, and research and commercialization challenges. The survey is lengthy—about 20 minutes to complete—but essential in building the new Roadmap. It’s time to make yourself heard!

Ribbon Bio, a Vienna-based synthetic biology company, is redefining DNA synthesis by creating long, complex sequences of up to 20 kilobase pairs with exceptional accuracy. Serving industries like biopharma, agriculture, and gene editing, its technology enables breakthroughs from new medicines to sustainable agriculture. Ribbon Bio emerged from a need for precise DNA molecules that existing vendors couldn’t deliver. Using machine learning, the company developed a novel synthesis approach and has since become a leader in the field. Divya Vijay Pratheek, Ribbon Bio’s Associate VP, emphasized that the company’s EIC Scaling Club membership is an excellent opportunity for peer-to-peer learning: "It's amazing how much you can learn from others who are on a similar path. Talking to other startups from different countries, really opened our eyes to the challenges we all face [..]” Discover more about Ribbon Bio’s journey and its impact: [Link in the comments]. Yours, EurA AG, Hello Tomorrow, Tech Tour, EuroQuity - Bpifrance, IESE Business School, Webrazzi / Tech.eu and the European Innovation Council and SMEs Executive Agency (EISMEA) Gilles Le Cocguen; Nassima Ferahtia; William Stevens; Teresa Cunha; Nicolette Komitska; Denitsa Nenkova; Yasemin Baran; Iva Tchetinova; Ricardo Greenfield; Valentin Marin; Etienne Pebrier; Josemaria Siota; Alberto Garcia Picazo; Alizée Blanchin; Lucas MAURICE; Carmo Cupertino de Miranda; Oriana B.; Cristiana Gonçalves; Rute Mata João; Joana Bragança; Márcia Macieira; Jan Bernlöhr; Marc Ranchon; Irmak Acar; Julia Gifford #EUinnovation #biotech #syntheticbiology #DNAsynthesis

The Flinn Foundation and SRI International are working with Arizona leaders on the next iteration of Arizona’s Bioscience Roadmap. And we need your voice:   SRI has launched a survey to understand Arizona’s bioscience ecosystem—competitiveness, talent pipeline, organizational needs, and research and commercialization challenges. The survey is lengthy but essential in building the new Roadmap. Giving us 20 minutes will ensure that your perspective is considered. https://lnkd.in/gcXfARiC

April 10 at 6pm PT. We have another incredible Innovator’s Workbench event planned, featuring Ted W. Love, MD, chair of the board of the Biotechnology Innovation Organization. Innovation Fellowship alum Uday Kumar, a senior advisor at Stanford Biodesign, will chat with Dr. Love about his journey into biotechnology innovation and the need to take on large, complex challenges to drive greater health equity for all populations. Don’t miss it!  Registration link in the comments. #innovationeducation #biotech #healthtech #healthequity

🥳 It was a great start to our Bavarian pre-seed funding programme 👉 “#𝗺4𝗔𝘄𝗮𝗿𝗱 - 𝗣𝗿𝗲-𝗦𝗲𝗲𝗱 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲” 👈 last week - the information event was very well attended. More than 60 interested parties took part to clarify any final questions. And things are just getting started! Now, let’s give us your insights into your idea. Impress the m4 Award team with a written 5-pager brief description, which includes: 👉 Your business idea / #businessmodel with development status and scientific as well as technical objectives of the project; 👉 A market/competition overview 👉 Your unique selling points 👉 The property rights situation/strategy, a work plan and financial plan 👉 the founder and project team An #entrepreneur that took these steps before you, is Dr. Nils A. Kulak of PreOmics GmbH, m4 Award winner of 2013 and spin-off of a working group around #proteomics pioneer Prof. Dr. Matthias Mann of the Max Planck Institute of Biochemistry in #Martinsried. Nils says: 🗣️ „For us, the m4 Award was the first essential stepping stone towards a successful start of our company.“ That should be a great encouragement! PreOmics is a company providing proteomic solutions for LC-MS and empowers its clients in #lifesciences to establish biological knowledge through efficient, reliable solutions and workflows that set the standard for protein analysis. The teams envisages a future with #revolutionary #proteomicdiscovery processes open for everyone: Tools that reveal hidden causes of #diseases, ensure sustainable nutrition, and provide diagnoses that enhance lives and society. You want to follow their path? Then find more information and our application form at ℹ️ www.m4-award.org #m4Award2025 #innovationfromBavaria #biotechnology #research #spinoff #entrepreneurship #preseed #Bavaria #MassSpec

🌌🚀Charting the Space Biotech Landscape As the space industry matures, a new frontier is emerging: space biotech. The sector holds great potential for driving innovation and market value both in space and on Earth. 💡 Did you know: If the pharmaceutical industry successfully collaborates with the space biotech industry, it is estimated that it could capture as much as ~$3-4bn of additional revenue growth. In collaboration with Cx Bio, and SpaceRadar, we've developed a comprehensive breakdown of the space biotech industry. 🔍 Key Highlights: 🔵 Informative Sector Categories: Distinct space biotech market categories based on proximal focus areas. 🔵 Market Drivers Explained: Details on market drivers including notable funding rounds and recent M&A activity. 🔵 Key Industry Players: A look at who is leading the way in the space biotech industry and how key innovations and research are being applied in space and on Earth. 🚀 Ready to Explore More? Download our comprehensive market map featuring over 90 companies in the space biotech industry and check out the Space Impulse Market Intelligence where you'll find Space Biotech market segments, funding data, company sizes, locations, and key deals. 📊 https://lnkd.in/eiy8SHXG #SpaceBiotech #Innovation #MarketMap #DownloadNow #SpaceTech #MicrogravityResearch

This week, Hologenomix Life Sciences became the first company to utilize our brand-new 𝐒𝐡𝐚𝐫𝐞𝐝 𝐒𝐞𝐫𝐯𝐢𝐜𝐞 𝐋𝐚𝐛 at Biotech Campus Delft! 🌱 This exciting milestone marks a new chapter in our journey to accelerate innovation in biotech. Hologenomix is a pioneering force in the field of multi-omics to develop early disease diagnosis tools. Their innovative approach aims to revolutionize healthcare by enabling more precise and early detection of diseases, ultimately improving patient outcomes. By choosing our facilities, Hologenomix is setting the tone for the transformative work that will take place here. Our Shared Service Lab, a fully equipped ML-2 lab of 63 m², provides a unique, low-barrier environment to boost your innovation. This dynamic environment allows you to conduct experiments, initiate and develop your cutting-edge technologies, and accelerate your research without the need for significant upfront investments. For a fixed monthly fee, you can rent a lab bench for periods ranging from 1 to 12 months. Our facilities include specialized equipment and expert support tailored for various applications, including particularly DNA assembly and strain engineering. Also, if you are looking for a lab to perform strain screening, media selection experiments, process development, and downstream processing such as product formulation and application, please get in contact to discuss possibilities. 🚀 If you're a scientist, startup, or company eager to contribute to the next big breakthrough in biotech, our doors are open! Join us and be part of a thriving community dedicated to creating a sustainable future through biotechnology. For more information, reach out to Jasper Driessen today. Our Shared Service Lab is co-funded by the European Union. #PlanetBio #BiotechInnovation #Biotechnology #Sharedlab #MultiOmics #EarlyDiagnosis #BiotechCampusDelft #SustainableFuture

🚀 United for Bavaria's Biotech Future: The Round Table Numerous institutions are investing not only their expertise but also a great deal of passion ❤️ to advance biotechnology in Bavaria. At the "Round Table of the Bavarian Biotechnology Cluster & Partners", organized by BioM Biotech Cluster Development GmbH, over 20 participants gathered at the IZB - Innovation and Start-up Center Biotechnology on September 26 – including representatives from BioPark Regensburg GmbH, Innovations- und Gründerzentrum (IGZ) Würzburg, Invest in Bavaria - The Business Promotion Agency of the State of Bavaria, Bayern Kapital, Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie, and Bayerisches Staatsministerium der Finanzen und für Heimat – to name just a few. 🌐 Topics such as patents, the challenge of early-stage financing, and the need for more government support were discussed among many others. 💬 This led to the creation of important connections between the actors and their projects – fostering collaboration and networking! 🤝 A great example: BioM and the Bavarian AI Agency presented their joint cross-cluster project, "AI in Biotechnology." 🤖🔬 The objectives: To identify technical and thematic interfaces in the application of AI within biotechnology and provide companies with practical advice for implementation. 🎉 A big thank you to Ralf Huss, Birgitta von Glass, and the entire BioM Biotech Cluster Development GmbH team for organizing this fantastic event and enabling such valuable discussions! #Biotechnology #Innovation #AI #Bavaria #BioM #IZB

We are excited to present our latest interview with Charlotte Broennimann, Product Manager at SEED Biosciences, showcasing their innovative Dispen3D technology. This groundbreaking product is set to transform single-particle isolation and dispensing, offering unparalleled precision and efficiency for researchers. Charlotte shares how Dispen3D is setting new standards in single-cell biology, driving advancements in drug discovery, personalized medicine, and regenerative therapies. Here are some key highlights: 🔬 Advanced Precision: Dispen3D enables high-precision experiments, crucial for cutting-edge research. 🌱 Biodegradable and Efficient: Utilizing magnetic chitosan, Dispen3D emphasizes environmental friendliness while enhancing research outcomes. ⚙️ Seamless Integration: Compatible with existing lab equipment, ensuring smooth adoption without overhauls. 🧬 Automation Benefits: Reduces human error and ensures reproducibility, saving time and resources. 💡 Transformative Impact: Case studies reveal significant improvements in drug screening and personalized medicine applications. Discover the key benefits and transformative potential of Dispen3D in improving research outcomes and laboratory workflows. 🔗Read the interview here: https://lnkd.in/ey6SiHXv #Innovation #Biotechnology #CellCulture #DrugDiscovery #PersonalizedMedicine #RegenerativeTherapies #Research #Dispen3D #SEEDBiosciences #LabTech #ScientificAdvancement

🌱🔬 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐀𝐥𝐞𝐫𝐭: 𝐋𝐨𝐰-𝐂𝐨𝐬𝐭 𝐂𝐮𝐬𝐭𝐨𝐦 𝐏𝐡𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐀𝐜𝐜𝐞𝐬𝐬 𝐓𝐫𝐢𝐚𝐥𝐬! 🔬🌱 PhenomUK is thrilled to announce a groundbreaking funding opportunity aimed at tackling the challenges of low-cost custom phenomics. 🚀 We're calling upon researchers and innovators across the UK to submit their proposals for projects focusing on the development, application, and replicability of affordable, tailored phenomics equipment. 🎯 Our Goal:  Our aim with this initiative is clear: to empower researchers by providing the tools they need to conduct phenomics experiments without breaking the bank. We're seeking projects that refine existing equipment for replication or implement designs from elsewhere, fostering collaboration and resource-sharing within the plant phenomics community. 🛠 What We're Looking For:  Applications may involve the development of custom sensors, imaging devices, or other phenomics tools. Whether it's standardizing a proprietary kit for wider use or overcoming technical barriers, we're eager to support projects that push the boundaries of innovation in phenomics research. 🌟 Why You Should Apply:  Gain funding to advance your phenomics solutions.  Contribute to the growth of the UK research community.  Address technical challenges and foster collaboration.  Make a meaningful impact on plant phenomics research. ⏰ Apply Now:  Applications will be reviewed on a rolling basis, so don't delay! Head over to the PhenomUK website for more details and to submit your proposals. With limited funding available, seize this opportunity to drive change and make your mark in the world of phenomics. 🌿 Together, Let's Grow:  We're excited to see the innovative proposals that emerge from this call and to work together in advancing low-cost custom phenomics solutions. Join us on this journey as we pave the way for a brighter future in plant research! #PhenomicsResearch #Innovation #FundingOpportunity #PhenomUK #ResearchCommunity International Plant Phenotyping Network - IPPN PhenomUK Research Infrastructure Tracy Lawson Claire Hayes